In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...

Good afternoon, and thank you for joining the ReShape Lifesciences Third Quarter 2024 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications. Good afternoon, ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...